M&A Deal Summary

Theravia Acquires Addmedica

On July 19, 2022, Theravia acquired life science company Addmedica from Merieux Equity Partners

Acquisition Highlights
  • This is Theravia’s 2nd transaction in the Life Science sector.
  • This is Theravia’s 2nd transaction in France.

M&A Deal Summary

Date 2022-07-19
Target Addmedica
Sector Life Science
Buyer(s) Theravia
Sellers(s) Merieux Equity Partners
Deal Type Merger

Target

Addmedica

Neuilly sur Seine, France
Addmedica is a pharma company focused on developing and marketing medical products for rare diseases and niche markets. Addmedica is based in Neuilly sur Seine, France.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Theravia

Neuilly-sur-Seine, France

Category Company
Sector Life Science
DESCRIPTION

Theravia is an international pharmaceutical laboratory specializing in rare or neglected diseases. Theravia is headquartered in Neuilly-sur-Seine, France.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Merger M&A Deals 2 of 2
Country: France M&A 2 of 2
Year: 2022 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-19 Laboratoires CTRS

Boulogne-Billancourt, France

Laboratoires CTRS is a French pharmaceutical company focused on developing and marketing drugs for rare diseases and with a strong and growing international presence. Its main areas of expertise are Hereditary metabolic diseases and Oncology-haematology-immunology. Laboratoires CTRS was founded in 2002 and is based in Boulogne-Billancourt, France.

Buy -

Seller(S) 1

SELLER

Merieux Equity Partners

Investor Investor Investor Investor


Category Growth Capital Firm
Founded 2009
PE ASSETS 1.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.


DEAL STATS #
Overall 5 of 9
Sector: Life Science M&A 3 of 6
Type: Merger M&A Deals 2 of 2
Country: France M&A 3 of 5
Year: 2022 M&A 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-19 Laboratoires CTRS

Boulogne-Billancourt, France

Laboratoires CTRS is a French pharmaceutical company focused on developing and marketing drugs for rare diseases and with a strong and growing international presence. Its main areas of expertise are Hereditary metabolic diseases and Oncology-haematology-immunology. Laboratoires CTRS was founded in 2002 and is based in Boulogne-Billancourt, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-21 Piercan

Port-en-Bessin, France

Piercan is an isolator and dry-box gloves manufacturer for the pharmaceutical and nuclear industries. The group operates 3 production sites located in France and in the US (2 glove and technical part production sites; 1 plastic part production site). Piercan was founded in 1948 and is based in Port-en-Bessin, France.

Buy -